SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Net loss attributable to Sanara MedTech common shareholders	$ (7,921,914)	$ (4,356,440)
Weighted average shares used to compute diluted net loss per share	7,341,580	5,734,537
Basic and diluted net loss per share attributable to common shareholders	$ (1.08)	$ (0.76)